A purple and pink letter v on a white background.
August 24, 2018

2two5™: An Effective Advertising Solution for Aesthetic Clinics

With an ever-growing number of marketing and advertising options, services, and methods that seemingly change in price, regulation, or algorithm each day, getting the most from your marketing efforts can be a drain on your time and budget. Running a medical aesthetics business is a demanding job, requiring constant efforts in patient acquisition and retention. The fine balancing act keeps your hands full and let’s be honest, online advertising isn’t everyone’s forte. Even if you’ve streamlined and simplified your marketing strategy, the learning curve can be daunting. In business, it’s important to save your time for the skills and services you can offer that make the greatest impact on your overall success—and that’s where we’d like to step in and introduce our new advertising agency exclusive to Venus Concept customers, 2two5™.  

What Is 2Two5™?

At Venus Concept, we’re focused on helping our clients achieve business success through a lineup of cutting-edge devices and skin care, alongside our industry-leading clinical education, practice enhancement, and marketing programs that prioritize your needs. Our new 2two5™ agency is the perfect extension to our customer partnerships. Even the name, 2two5™, a reference to the number of days it takes Venus to orbit the Sun, highlights our company’s philosophy that everything we do will always revolve around you and your needs.

An exclusive advertising agency for Venus Concept customers, 2two5™ connects prospective patients with non-invasive service providers by delivering the most compelling ads to the right audience, at the right time. To do this, we utilize our Advanced Conectivity Module (ACM) and non-identifiable demographic data to optimize your advertising targeting. In other words, while you specialize in medical aesthetics, our 2two5™ team specializes in marketing to the right audience at the right time. So you can keep busy doing what you do best.

What Sets 2two5™ Apart? 

The first factor that makes our advertising agency a serious contender is an experienced and skilled team. 2two5™ is staffed by advertising executives from digital agencies, creative agencies, and aesthetic marketing firms whose work is backed by official partnerships with two of the largest aesthetic review sites in the country.

These official channel partnerships offer customers improved local search authority. As our client, you gain access to enhanced capabilities and customer service that most small to mid-sized practices cannot afford. As a signed strategic partner with Doctor.com, 2two5™ offers deep industry-specific capabilities and experience. With this platform, your medical aesthetics clinic is able to easily announce the addition of new cutting-edge devices and services, ensuring an improved competitive edge in your online presence.

Finally, 2two5™’s ACM technology uses non-identifiable demographic data to direct more cost-efficient online advertising campaigns for Google, Facebook, Bing, Yahoo, and Instagram—this is an industry first and available only to our Venus Concept customers. Our level of connectivity, demographic accuracy, and tracking is unparalleled in the industry and it’s exclusively available at a much lower cost to Venus Concept customers compared to our top advertising agency competitors.

The Bottom Line

The 2two5™ agency was built in response to overwhelming demand from our customers for advertising services that medical and non-medical practices can trust. With many medical aesthetic providers concerned about marketing costs, the efficacy of competitor plans, the risk of exaggerated results, and more, 2two5™ focuses on transparency and a customer-first business model. As a disruptive force in medical aesthetics advertising, we ensure our clients receive a better rate, improved marketing results, and a partner that really cares about their success.

Interested in upgrading your Venus Concept partnership to include the industry-leading advertising services of 2two5™? Contact us today!

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.